| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LOXO ONCOLOGY INC COM | 300,722 | 12,654,000 | 10.70% | ||
| 2 | ATRICURE INC | 506,946 | 9,708,000 | 8.21% | ||
| 3 | NXSTAGE MED INC COM | 216,119 | 5,798,000 | 4.90% | ||
| 4 | ALDER BIOPHARMACEUTICALS INC | 221,013 | 4,597,000 | 3.89% | ||
| 5 | BIOCRYST PHARMACEUTICALS | 541,128 | 4,545,000 | 3.84% | ||
| 6 | Sunesis Pharmaceuticals, Inc. | 867,529 | 3,557,000 | 3.01% | ||
| 7 | BLUEPRINT MEDICINES CORP COM | 82,500 | 3,299,000 | 2.79% | ||
| 8 | GALAPAGOS NV | 35,359 | 3,048,000 | 2.58% | ||
| 9 | BEIGENE LTD | 81,231 | 2,974,000 | 2.52% | ||
| 10 | APPLIED GENETIC TECHNOL CORP | 411,000 | 2,836,000 | 2.40% | ||
| 11 | ARDELYX INC COM | 221,738 | 2,805,000 | 2.37% | ||
| 12 | INSULET CORPORATION | 63,484 | 2,736,000 | 2.31% | ||
| 13 | AEGLEA BIOTHERAPEUTICS INC | 350,392 | 2,610,000 | 2.21% | ||
| 14 | ISHARES TR | 8,700 | 2,551,000 | 2.16% | ||
| 15 | INSULET CORP 2 06/15/2019 | 2,250,000 | 2,537,000 | 2.15% | PRN | |
| 16 | NEUROCRINE BIOSCIE COM USD0.001 | 58,508 | 2,533,000 | 2.14% | ||
| 17 | MACROGENICS INC | 119,200 | 2,217,000 | 1.88% | ||
| 18 | BioTelemetry Inc | 75,000 | 2,171,000 | 1.84% | ||
| 19 | AERIE PHARMACEUTICALS INC COM | 46,770 | 2,121,000 | 1.79% | ||
| 20 | PROTALIX BIOTHERAPEUTICS INC | 2,500,000 | 1,963,000 | 1.66% | PRN | |
| 21 | SPECTRANETICS CORP | 65,496 | 1,908,000 | 1.61% | ||
| 22 | RADIUS HEALTH INCORPORATED COM NEW | 48,809 | 1,886,000 | 1.60% | ||
| 23 | CELLECTIS S A | 76,404 | 1,834,000 | 1.55% | ||
| 24 | CARA THERAPEUTICS INC | 95,322 | 1,753,000 | 1.48% | ||
| 25 | IMMUNOMEDICS INCORPORATED | 252,574 | 1,634,000 | 1.38% | ||
| 26 | CIDARA THERAPEUTICS INC | 208,458 | 1,626,000 | 1.38% | ||
| 27 | FOAMIX PHARMACEUTICALS LTD | 325,667 | 1,612,000 | 1.36% | ||
| 28 | RIGEL PHARMACEUTICAL INC | 473,478 | 1,567,000 | 1.33% | ||
| 29 | ADVAXIS INC COM NEW | 172,000 | 1,405,000 | 1.19% | ||
| 30 | XENON PHARMACEUTICALS INC | 339,614 | 1,358,000 | 1.15% | ||
| 31 | UNIQURE NV | 203,907 | 1,179,000 | 1.00% | ||
| 32 | JOHNSON & JOHNSON | 9,400 | 1,171,000 | 0.99% | ||
| 33 | SCYNEXIS INC | 381,900 | 1,054,000 | 0.89% | ||
| 34 | NEURODERM LTD | 37,438 | 994,000 | 0.84% | ||
| 35 | BIOLINERX LTD | 1,000,000 | 961,000 | 0.81% | ||
| 36 | DERMIRA INC COM | 28,000 | 955,000 | 0.81% | ||
| 37 | VOYAGER THERAPEUTICS INC | 71,320 | 944,000 | 0.80% | ||
| 38 | SYNERON MEDICAL LTD | 85,947 | 907,000 | 0.77% | ||
| 39 | TANDEM DIABETES CARE INC COM | 724,286 | 869,000 | 0.74% | ||
| 40 | ArQule Inc | 807,008 | 855,000 | 0.72% | ||
| 41 | ACHILLION PHARMACEUTICALS IN | 196,500 | 827,000 | 0.70% | ||
| 42 | MINERVA NEUROSCIENCES INC COM | 101,317 | 821,000 | 0.69% | ||
| 43 | BLUEBIRD BIO INC COM | 9,000 | 818,000 | 0.69% | ||
| 44 | Exactech Inc | 31,636 | 797,000 | 0.67% | ||
| 45 | Stereotaxis Inc | 1,372,862 | 782,000 | 0.66% | ||
| 46 | CASCADIAN THERAPEUTICS INC | 185,259 | 767,000 | 0.65% | ||
| 47 | NOVADAQ TECHNOLOGIES INC | 95,841 | 747,000 | 0.63% | ||
| 48 | IRONWOOD PHARMACEUTICALS INC DBCV 2.250 6/1 | 573,000 | 714,000 | 0.60% | PRN | |
| 49 | NEOS THERAPEUTICS INC COM | 95,273 | 686,000 | 0.58% | ||
| 50 | ZOGENIX INC | 59,778 | 649,000 | 0.55% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-17-000018, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
